ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
Closed while relocating
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Fibromyalgia study involves medication and conversation
Friday 12 March 2010
Fibromyalgia Study Involves Medication and Conversation
INDIANAPOLIS — The Indiana University Fibromyalgia Clinical Research Center is evaluating communication as a therapeutic tool in treating the often painful yet common disease.
This is the third in a continuing series of research studies for fibromyalgia entitled Drug and Talk Therapy for Fibromyalgia.
The IU center is conducting this study to better understand how talk therapies, such as education and cognitive behavioral therapy, can improve the therapeutic benefits of medications for fibromyalgia.
Savella®, also known as milnacipran, is an FDA approved drug for fibromyalgia. The safety and efficacy of Savella has been established in two nationwide clinical studies involving more than 2,000 patients with fibromyalgia. Since Savella has already been shown to be effective when used in isolation to treat fibromyalgia, IU researchers are conducting the study to determine whether combination treatment (Savella + talk therapy) is more effective than Savella alone or talk therapy alone.
Participants are randomly assigned to receive either Savella or a placebo (sugar pill) and will receive either cognitive behavior therapy or an educational phone series.
Those interested in learning more about this study should contact the Fibromyalgia Clinical Research Center at 317-278-3971.
The study is funded by National Institutes of Health.
# # #
The article originally appeared here.
blog comments powered by Disqus